Palvella Therapeutics (PVLA) Interest Coverage Ratio (2013 - 2026)
Palvella Therapeutics' (PVLA) quarterly Interest Coverage Ratio came in at 0.05 in Q1 2026, up 76.82% year-on-year from 0.03 in Q1 2025, and up 76.82% on a QoQ basis from 0.2 in Q1 2025.
Palvella Therapeutics (PVLA) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Palvella Therapeutics (PVLA) has 14 years of Interest Coverage Ratio data on file, last reported at 0.05 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 76.82% year-over-year to 0.05 in Q1 2026; TTM through Mar 2026 was 0.15, a 72.29% increase from a year earlier, with the FY2025 full-year figure at 0.29, down 94.76% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 0.05, up from 0.2 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for PVLA reached as high as 4.13 in Q2 2023 and fell as low as 100.28 in Q2 2024.
- Historically, Interest Coverage Ratio has averaged 21.4 across 5 years, with a median of 20.55 in 2022.
- Across the five-year window, Interest Coverage Ratio soared 120.08% in 2023 and plunged 2530.34% in 2024, its largest moves.
- Year by year, Interest Coverage Ratio stood at 14.4 in 2022, then jumped by 41.9% to 8.37 in 2023, then slumped by 188.32% to 24.12 in 2024, then surged by 99.15% to 0.2 in 2025, then jumped by 76.82% to 0.05 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 0.05 in Q1 2026, 0.2 in Q1 2025, and 24.12 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | -0.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.05 |
| Mar 31, 2025 | -0.20 |
| Dec 31, 2024 | -24.12 |
| Sep 30, 2024 | -23.01 |
| Jun 30, 2024 | -100.28 |
| Dec 31, 2023 | -8.37 |
| Sep 30, 2023 | -23.61 |
| Jun 30, 2023 | 4.13 |
| Mar 31, 2023 | -31.02 |
| Dec 31, 2022 | -14.40 |
| Sep 30, 2022 | -24.34 |
| Jun 30, 2022 | -20.55 |
| Mar 31, 2022 | -12.43 |
| Dec 31, 2021 | -15.71 |
| Sep 30, 2021 | -31.69 |
| Jun 30, 2021 | -27.94 |
| Mar 31, 2021 | -7.23 |
| Dec 31, 2020 | -17.73 |
| Sep 30, 2020 | -21.67 |
| Jun 30, 2020 | -7.76 |